The MedicX Fund Limited Notice of dividend (2900V)

TIDMMXF

RNS Number : 2900V

The MedicX Fund Limited

01 November 2017

Press Release

For immediate release

1 November 2017

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Notice of dividend

The Directors have approved a quarterly dividend of 1.5p per Ordinary Share in respect of the period 1 July 2017 to 30 September 2017. This will bring the total dividends declared in respect of the financial year ended 30 September 2017 to 6.0p per Ordinary Share, an increase of 0.84% over the dividends totalling 5.95p declared for the previous year ended 30 September 2016. The dividend will be paid on 29 December 2017 to ordinary shareholders on the register as at 17 November 2017 (the "Record Date"). The corresponding ex-dividend date will be 16 November 2017.

The Company is offering qualifying shareholders the opportunity to take new ordinary shares in the Company, credited as fully paid, in lieu of the cash dividend to be paid on 29 December 2017, by participating in the Scrip Dividend Scheme (the "Scheme") previously put in place by the Company on 5 May 2010. Following the Company's notice of entry into the UK REIT regime effective from 1 October 2017, the Scrip Dividend Scheme Document was updated to illustrate to shareholders the mechanics of the possibility of a scrip alternative being offered on a dividend which is paid partly or fully as a Property Income Distribution ("PID") as well as a link to www.signalshares.com where shareholders can elect online to receive their dividend in the form of new shares rather than cash.

The option to participate will be available to shareholders until 6 December 2017 (the "election date"). Further information on the Scheme, together with a copy of the Scheme Document (which contains the terms and conditions of the Scheme) and relevant mandate form document, is available for inspection at the National Storage Mechanism (http://www.morningstar.co.uk/uk/nsm), or through the Scrip Dividend portal on the Company's website (http://www.medicxfund.com/investors/scrip-dividend-scheme.aspx)

No PID is included in this final dividend for the year ended 30 September 2017.

End

For further information please contact:

   MedicX Fund                                                                   [phone] 

David Staples, Chairman

   Octopus Healthcare Group                                               [phone] 

Mike Adams, Chief Executive Officer

Buchanan [phone]

Charles Ryland/Vicky Hayns

Information on MedicX Fund Limited

MedicX Fund Limited (the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 156 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over GBP1.1 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages GBP7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 100,000 customers

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DIVMMMGMDMGGNZM

(END) Dow Jones Newswires

November 01, 2017 10:14 ET (14:14 GMT)